Our mission is to make commerce and its suppliers more efficient and data-driven. Our services are used by some of the largest brands in the Nordic countries, and we are proud to serve over 100 customers. What we do Our tools and expertise are based on combining quality-assured data with interactive maps. In our cloud-based platform, it’s easy to visualize data and work in a map and/or table environment to identify where business opportunities, potential, and target groups exist. How we work We offer a unique combination of data and powerful map tools. In our platform, relevant data and documentation are analyzed for quick and precise decisions. We provide tools for establishment, analysis, target group insights, prospecting, and optimization of sales forces and sales districts.

SalesKong is an AI sales assistant that helps B2B teams execute deals faster by automating the work between meetings: research-grade prep, accurate notes, and follow-ups written in your own tone, plus CRM-linked deal qualification and coaching. Reps spend less time on admin and more time on customers, while leaders get cleaner, more reliable pipeline.

The live entertainment industry still runs on analog processes,scattered Google Docs, Excel sheets, and manual workflows.” Jocky is building the digital infrastructure for live entrainment. Collecting Invoices, scheduling, booking and live entertainment data so that venues, artists, and agencies can run their operations from a single place.

Vi skabte NODA i 2020, fordi vi savnede en drik med ægte ingredienser, lavt kalorieindhold og uden sukker, kunstige sødestoffer eller tilsætningsstoffer. Alt, hvad vi fandt, indeholdt unødvendige ingredienser, selv “sunde” alternativer. Resultatet blev NODA – en genopfindelse af sodavanden. Med 30% presset økologisk frugt og danskvand tilbyder vi en naturlig, lækker og forfriskende drik, som kan nydes af alle. Vores mission: At skabe drikkevarer med fokus på økologi, sundhed og bæredygtighed, som folk kan nyde dagligt. NODA er til alle, der ønsker et forfriskende, naturligt og lækkert alternativ til traditionelle sodavand. Læs mere om vores tilgang her: https://nodacph.com/pages/omtanke

Only 7.9% of new medicin is approved for phase 1 clinical programs - life saving cures are being scrapped because of poor reproducibility. Today, researchers designing complex in vitro and in vivo experiments jump between many tools that do not talk to each other. Protocols are written in free text, naming is inconsistent, raw data is scattered across drives, and inventory and cell banks are tracked separately. This makes it hard to reproduce experiments, compare results across projects, trace which cell material went into which batch, and satisfy regulatory expectations. Small and mid-sized labs often cannot afford enterprise platforms like Benchling or Dotmatics, so they manually glue everything together and rarely get to use advanced analytics or AI. BioPilot solves this by standardising the full early-to-in-vivo CTR pipeline in one product. Users can register and template in vitro experiments (differentiation, expansion, cryopreservation, device testing, etc.) and in vivo studies (animals, groups, dosing, housing, ethics documents) using fixed ontologies. This gives every experiment a structured schema and a precise schedule of readouts, barcodes and data types to collect. Raw data (FACS, scRNA-seq, imaging, counters, bioreactor logs, etc.) is then automatically linked back to the right experiment, condition and sample. On top of this, BioPilot offers: • Inventory and cell bank tracking that makes it trivial to trace which vial, edit or expansion batch was used where. • Live bioreactor monitoring with alarms (email / phone) to prevent losing expensive batches. • A growing library of free analytical tools, including automated FACS gating, scRNA-seq pipelines and image analysis that can feed results straight back into the experiment records. • A global ontology service for vendors, instruments, cell lines, species and process terms, with a roadmap for a public API. Because everything is structured and queryable, BioPilot makes it much easier to compare experiments, run Bayesian optimisation on process parameters, and let AI suggest next-step experiments. The pricing is kept aggressively low (free tier plus a simple paid tier based on storage), so smaller biotech and academic groups can access capabilities that are normally reserved for organisations with large software budgets. In short, BioPilot aims to become the operating system for cell therapy R&D: a single, affordable platform where experiments are planned, executed, monitored and analysed in a way that is standardised enough for automation and flexible enough for real-world biology.

We are a specialized transformation firm dedicated to solving the most complex, entrenched challenges facing organizations in the innovation ecosystem. We believe that true, lasting change requires tackling challenges systemically - by working with how organizations think and how they work. The Impact You Will Drive Most "transformation" efforts fail because they either focus only on surface-level strategy or deploy technology that automates existing inefficiencies. You will join us to solve this challenge: Systemic Diagnosis: You will help us move beyond symptoms to identify the true root causes of friction and inefficiency within complex organizational systems. Human-Centered AI Deployment: You will liberate human potential by designing and building custom AI and automation solutions that free up brilliant minds from low-value, repetitive work, empowering them to focus on high-impact, strategic tasks. Why Join Our Team? We are driven by a mission to make organizational work meaningful and impactful. Autonomy and Ownership: We operate on the principle of co-creation, ensuring clients own their systems and data. We have large focus data sovereignty and privacy implications. Complex Challenges: You will constantly be exposed to strategic and technical problems where human behavior and capacity is the driving factor for how we go about automations and AI-deployment. Purpose: If you are a builder who thrives on tackling complexity, values autonomy, and believes technology should fundamentally serve people, join us in driving meaningful, systemic change.

Lyfta is building the operating system for strength training. Today, millions of people go to the gym without a clear plan, without tracking properly, and without understanding whether they’re actually progressing. Most tools in the space optimize for engagement, not outcomes. We think that’s the wrong approach. Strength training is one of the highest-leverage activities for long-term health, but only if it’s structured, consistent, and measurable. That’s what we’re building, a system that helps people train with clarity, track real progress, and improve over time. Lyfta is already used by over a million people globally, with strong growth month over month. We’re still early, but the ambition is clear: build the product people rely on to get stronger, not just another app they use occasionally.

Oppa Oppa is a Danish skincare store bringing the best of Korean beauty to Scandinavia. We curate and import top-rated Korean skincare products — from well-known favorites like Anua and Beauty of Joseon to insider picks still undiscovered in the West. Our mission is to make premium Korean skincare accessible, trustworthy, and enjoyable for everyone in Denmark. By combining authentic Korean expertise with Scandinavian simplicity, we help people achieve healthy, glowing skin through products that truly work. Oppa Oppa is currently in its early growth stage, expanding our online presence and building a passionate community through creative content, social media, and e-commerce.

Is It Time to Pivot from Corporate to Co-Founder? Great startups don’t fail because of bad ideas - they stall because they can’t reach the market. From deep-tech to consumer products, many early-stage ventures have strong teams and promising solutions - but lack the commercial insight to grow. Commercial Co-Founder is a programme designed for professionals ready to pivot out of traditional commercial roles and into high-impact roles within early-stage startups.

Breeze IP is a modern IP Portfolio Management software company dedicated to simplifying and streamlining intellectual property management for both IP owners and agencies. Founded in 2023, our mission is to modernize the way businesses handle their IP assets by providing intuitive, efficient, and comprehensive tools that cater to the evolving needs of the IP industry. https://www.breezeip.com/

In modern society, living circular is difficult and time-consuming, therefore discouraging people from doing so and in turn damaging our progress towards a sustainable society. To tackle this problem, we're building Heycirc: An AI-powered, all-in-one marketplace for circular services. It enables people to easily buy/sell second-hand, lease (out), swap, repair, and refurbish, in turn making circular living the easiest and overall best option for consumers and business alike. Our vision is to become the world’s leading circular economy platform, empowering millions to embrace circular living, while creating a new standard for how we produce, use, and recover goods

FEESH...the feed for your fish Aquaculture is the fastest-growing food sector and is vital for meeting the protein needs of a growing global population. Yet, its growth is constrained by reliance on two unsustainable protein sources: fishmeal and soy protein concentrate (SPC). Fishmeal is produced from wild-caught fish, putting pressure on already fragile marine ecosystems, while soy production drives large-scale deforestation and carries a heavy carbon footprint. Both are also subject to volatile global markets, making aquafeed production environmentally damaging, expensive, and vulnerable. Insects, particularly Black Soldier Fly Larvae (BSFL), are an attractive and more sustainable alternative. They can be produced locally, upcycle organic waste streams into valuable protein, and have a low environmental footprint. However, despite this potential, insect meal remains a niche ingredient in aquafeeds. The main barrier is chitin, a fiber-like polymer in the insect exoskeleton that reduces digestibility and locks away valuable proteins. This limits inclusion rates of BSFL meal in aquafeeds to just 2–8%, far below the levels needed to meaningfully replace fishmeal and soy. At FEESH, we are solving this problem by applying a precision microbial fermentation platform, enhanced with ultrasonication pre-treatment, to upgrade BSFL meal into a high-performance protein ingredient. Our process disrupts the chitin-protein matrix, making proteins more bioavailable, reducing indigestible fiber, and enriching the lipid fraction with beneficial fatty acids such as EPA and DHA. Additionally, fermentation produces bioactive peptides and immunostimulatory compounds that improve gut health and disease resilience in fish. The result is a fermented insect meal with digestibility levels reaching 90–95%, enabling high inclusion rates of >20% in aquafeeds without compromising fish growth, palatability, or welfare. By combining biological and physical processing, FEESH unlocks the true nutritional potential of insects, transforming them from a niche supplement into a viable replacement for fishmeal and soy protein concentrate. This matters because the aquafeed industry needs scalable, circular, and climate-friendly solutions. Our innovation reduces dependence on environmentally destructive feed sources, cuts CO₂ emissions, and strengthens food system resilience. For insect producers, it creates new market opportunities with higher-value products. For aquafeed formulators and fish farmers, it delivers a sustainable, locally produced protein that supports both performance and animal health. And for society, it contributes to global food security and a more sustainable bioeconomy. FEESH is pioneering the next generation of aquafeed ingredients, designed not just to sustain aquaculture, but to make it thrive responsibly.

Dalea delivers a data platform for research within BioPharma and Life Sciences, providing familiar tools and a frictionless migration for researchers. Researchers forecast industry data volumes will double within 1 year, yet 60% of data is currently still stored on personal computers or in physical notebooks. Despite this issue, there is a clear market gap; two thirds of researchers within the field are dissatisfied with existing options on the market today. This is a major challenge for data replication and scientific collaboration. It stifles the value of created data and greatly inhibits discovery. Larger BioPharma companies resort to re-running experiments, as a faster alternative to looking up results. The market size for Electronic Notebooks and Laboratory Information Management Systems is expected to double in the next 10 years, with industry leaders breaking a staggering $6 billion valuation. Dalea is entirely EU-based, ensuring current and future compliance and data security. Our Academic version launches this Autumn, with an initial customer base secured through partnerships with leading academic labs. Ready to revolutionize research data? Explore our open roles and join us on the front lines of scientific innovation.

Remove the Noise. Find Focus. Achieve your goals. A simple visual tool to plan and implement your most important goals - without losing track. Visualize ideas, create structure, and track progress. Perfect for teams, entrepreneurs, educators, leaders, everybody who want to turn visions into measurable results. Use it for strategic planning, teaching, or personal productivity. Choose FocusMap if you want clarity, focus, and momentum in your projects – all in one place.

At Clause Out we know that it’s impossible to make good decisions, when policy makers are out of touch with real life consequences - and this didn't start with the current administration. We aim to give people in the U.S. an easy-to-use platform that provides them clear insight into all things moving about in the policy space, as well as a channel to voice their opinion on these developments. At the same time, we offer political advocacy groups the opportunity to test their policy drafts with the public and keep up with important updates on the policies close to their cause. In short, we're building a platform to bring people and policy closer together.